News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Dr. Dana M. Fowlkes Leaves His Position as Member of the Karo Bio AB Board of Directors
December 8, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: On December 8, 2008 Dr. Dana M. Fowlkes resigned his position as a member of the board of directors of Karo Bio (STO:KARO), effective immediately. This action was taken for personal reasons.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Layoff Tracker
GSK Cuts Unspecified Number of R&D Staffers
July 17, 2025
·
159 min read
·
BioSpace Editorial Staff
IN PARTNERSHIP WITH IQVIA
AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace
July 17, 2025
·
1 min read
·
Lori Ellis
Tariffs
Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in US as Tariffs Near
July 17, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff
July 16, 2025
·
2 min read
·
Heather McKenzie